Artigos

Search for articles

BJO Oncology - Placeholder

5-ALA-Induced Fluorescent Urine Cytology in Comparison with Conventional Cytology, BTA-TRAK, and NMP-22 Tests in the Diagnosis of Bladder Cancer

Abstract Introduction To assess the sensitivity fluorescent urine cytology induced by 5-aminolevulinic acid (5-ALA) in the diagnosis of bladder cancer and to compare the sensitivity and specificity with currently available markers approved by the United States Food and Drug Administration (FDA), bladder tumour antigen (BTA-TRAK, Bard Diagnostic Sciences, Redmond, WA, United...
BJO Oncology - Placeholder

Impact of Treatment Technique on Testicular Dose and Sexual Activity in Rectal Cancer Patients

Abstract Objective To estimate the incidental radiation dose delivered to the testicles in three-dimensional conformal radiotherapy (3DCRT), intensity-modulated radiotherapy (IMRT), and volumetric-modulated arc therapy (VMAT) in rectal cancer patients and its impact on sexual activity using a quality-of-life questionnaire. Materials and Methods The present study included 40 male patients, aged between 25...
BJO Oncology - Placeholder

Immunohistochemistry and next-generation sequencing for NTRK fusion detection in differentiated thyroid cancer of children, adolescents and young adults

ABSTRACT Introduction: Pan-TRK immunohistochemistry staining can assess the protein expression from NTRK gene fusions. A little is known about its utility in differentiated thyroid cancer samples from children, adolescents, and young adults patients. Objective:Investigate pan-TRKimmunohistochemistry sensitivity and specificity in differentiated thyroid cancer samples from children, adolescents, and young adults patients....
BJO Oncology - Placeholder

The average cost of treatment according to lung cancer stage using real-world data

ABSTRACT Introduction: Immunotherapy led to increased survival in advanced non-small cell lung cancer; however, it has also increased treatment costs. In this study, real-world data was used to evaluate the average cost of treatment of patients with lung cancer. Material and Methods: This is a retrospective study that extracted patient-level...
BJO Oncology - Placeholder

Bioequivalence study between two formulations of 10mg lenalidomide capsules in healthy male subjects under fasting conditions

ABSTRACT Objective: To evaluate pharmaceutical bioequivalence between two formulations of 10mg lenalidomide capsules in healthy male subjects under fasting conditions. Material and Methods: An open label, monocentric, randomized, 2x2 crossover study in 32 healthy men under fasting conditions comparing two formulations of lenalidomide capsules. Analyte concentrations in human plasma were...
BJO Oncology - Placeholder

Impact of advanced prostatic cancer treatment on quality of life and sexual function

ABSTRACT Introduction: The studying the quality of life after cancer treatment has become a priority in oncology. Objectives: To evaluate the impact of different treatments for recurrence prostate cancer on quality of life and sexual activity. Material and Methods: Two hundred patients with recurrence prostate cancer after initial treatment were...
BJO Oncology - Placeholder

Sociodemographic effect on stage at diagnosis of melanoma patients treated in a public cancer center in Brazil

ABSTRACT Introduction: Melanoma is the most aggressive type of skin cancer, with a continuous increase in its incidence worldwide. The prognosis of patients is favorable, and the treatment is relatively simple and inexpensive when diagnosed at an early stage. However, early diagnosis requires easy access to the health system. In...
BJO Oncology - Placeholder

The potential of telemedicine in alleviating out-of-pocket costs for oncological patients in the Brazilian public healthcare system

ABSTRACT Despite the absence of data regarding direct costs for healthcare, oncological patients from the Brazilian Unified Public Healthcare System often face significant financial burden due to out-of-pocket costs associated with their treatment. These costs include expenses for transportation, meals, non-covered medications, and the time spent on medical visits, tests,...
BJO Oncology - Placeholder

Evaluation of the impact of physical exercise on quality of life and clinical outcomes among women undergoing treatment for breast cancer

ABSTRACT To evaluate the association between the practice of physical exercises, quality of life and clinical outcomes in women diagnosed with and undergoing treatment for breast cancer. Cohort study, following-up women during 6 months after treatment beginning for breast cancer. A total of 149 participants were recruited for convenience in...
BJO Oncology - Placeholder

Percutaneous nephrostomy in cervical cancer patients: a retrospective analysis

ABSTRACT Objectives: To evaluate the outcome of patients with cervical carcinoma submitted to percutaneous nephrostomy due to malignant ureteral obstruction. Material and Methods: Retrospective cohort study with data obtained from medical records of patients diagnosed with cervical carcinoma with renal dysfunction (AKIN = stage 2) undergoing PCN for malignant obstructive...